Methodological quality scores of the included studies
Adequate randomisation? | Allocation concealment? | Blinding? Patients? | Blinding? Caregiver? | Blinding? Outcome assessors? | Incomplete outcome data addressed? Drop-outs? | Incomplete outcome data? ITT analysis? | Free of Suggestions of selective outcome reporting? | Similarity of baseline characteristics? | Co-interventions avoided or similar? | Compliance acceptable in all groups? | Timing of the outcome assessment similar? | Score maximum | Score study | Per cent | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ultrasound | |||||||||||||||
Haker and Lundeberg18* | − | + | + | + | + | + | − | + | + | + | + | + | 12 | 10 | 83 |
Lundeberg et al19* | − | + | + | + | + | + | + | − | − | + | + | + | 12 | 9 | 75 |
D'Vaz et al20 | + | + | + | − | + | + | − | + | ? | + | + | + | 12 | 9 | 75 |
Oken et al11 | + | ? | − | − | + | + | + | + | + | ? | ? | + | 12 | 7 | 58 |
Binder et al21* | − | + | + | + | − | + | − | − | − | − | + | + | 12 | 7 | 58 |
Stratford et al22* | + | + | − | − | + | + | + | − | − | − | + | + | 12 | 7 | 58 |
Davidson et al23 | + | ? | − | − | + | + | − | + | ? | + | + | − | 12 | 6 | 50 |
Langen-Pieters and Brantingham24 | + | ? | − | − | − | + | + | + | − | ? | + | − | 12 | 5 | 42 |
Pienimaki et al25 | ? | ? | − | − | ? | + | ? | + | + | ? | ? | − | 12 | 3 | 25 |
Laser | |||||||||||||||
Vasseljen et al26* | + | + | + | + | + | + | − | + | + | + | + | + | 12 | 11 | 92 |
Stergioulas27 | + | + | + | − | + | + | + | + | + | + | + | + | 12 | 11 | 92 |
Haker and Lundeberg28* | − | + | + | + | + | + | + | + | − | + | + | + | 12 | 10 | 83 |
Haker and Lundeberg18* | − | + | + | + | + | + | − | + | + | + | + | + | 12 | 10 | 83 |
Vasseljen et al26* | + | + | − | − | − | + | − | + | + | + | + | + | 12 | 8 | 67 |
Krasheninnikoff et al29* | − | + | + | + | + | − | − | − | + | − | + | + | 12 | 7 | 58 |
Lam and Cheing30 | + | ? | + | − | ? | + | + | + | + | ? | ? | + | 12 | 7 | 58 |
Basford et al31 | + | ? | + | − | + | + | − | + | + | − | + | − | 12 | 7 | 58 |
Lundeberg et al32* | − | + | + | + | + | − | − | − | − | − | − | + | 12 | 5 | 42 |
Gudmundsen33* | − | − | − | − | + | − | − | − | − | − | − | − | 12 | 1 | 8 |
Electrotherapy | |||||||||||||||
Coff and Caragianis34 | ? | − | − | − | ? | + | + | + | + | ? | + | + | 12 | 6 | 50 |
NourbakhshReza35 | ? | − | + | − | + | ? | ? | + | ? | ? | ? | + | 12 | 4 | 33 |
Pulsed electromagnetic field | |||||||||||||||
Uzunca et al36 | − | + | − | − | + | + | + | + | + | ? | ? | + | 12 | 7 | 58 |
Devereaux et al37 | ? | ? | + | − | + | + | + | ? | + | ? | ? | + | 12 | 6 | 50 |
Chard and Hazleman38* | − | − | + | + | + | − | − | − | − | − | − | + | 12 | 4 | 33 |
TENS | |||||||||||||||
Weng et al39 | ? | ? | ? | ? | ? | ? | ? | + | ? | ? | ? | ? | 12 | 1 | 8 |
ESWT | |||||||||||||||
Rompe et al40† | + | + | + | n.a. | + | + | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 6 | 100 |
Gunduzet al41 | + | + | + | ? | + | + | + | + | + | + | + | + | 11 | 11 | 100 |
Chung and Wiley42† | + | + | + | n.a. | + | − | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 5 | 83 |
Haake et al43† | − | + | + | n.a. | + | + | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 5 | 83 |
Pettrone and McCall44† | ? | + | + | n.a. | + | + | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 5 | 83 |
Mehra et al45† | + | − | + | n.a. | − | + | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 4 | 67 |
Speed et al46† | ? | ? | + | n.a. | + | + | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 4 | 67 |
Staples et al47 | + | ? | + | − | + | + | − | + | + | + | ? | + | 12 | 8 | 67 |
Spacca et al48 | + | ? | + | − | ? | + | + | + | + | ? | + | + | 12 | 8 | 67 |
Collins and Jafarnia49 | ? | − | + | − | + | + | + | − | + | − | + | + | 11 | 7 | 64 |
Pettrone and McCall44 | + | + | + | − | + | − | − | + | + | ? | ? | + | 12 | 7 | 58 |
Melikyan et al50† | ? | ? | + | n.a. | + | + | − | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 3 | 50 |
Rompe et al40† | ? | ? | + | n.a. | + | + | − | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 3 | 50 |
Levitt51† | ? | ? | + | n.a. | + | + | − | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 3 | 50 |
Radwan et al9 | + | ? | − | − | − | + | − | + | + | ? | n.a. | + | 11 | 5 | 45 |
Chung et al52 | ? | ? | + | − | ? | + | − | + | ? | ? | + | − | 12 | 4 | 33 |
Crowther et al53 | + | ? | − | n.a. | ? | − | + | n.a. | n.a. | n.a. | n.a. | n.a. | 6 | 2 | 33 |
Total positive scores per item | 19 | 19 | 29 | 11 | 28 | 32 | 17 | 25 | 17 | 11 | 18 | 26 |
*Articles included in the review of Smidt et al16 in which the Amsterdam-Maastricht consensus list was used to score the methodological quality.
†Articles included in the review of Buchbinder et al17 in which six specific criteria were used to score the methodological quality.
+, yes; −, no; ?, unclear/unsure; n.a. not applicable because these items were not used as quality criteria.